CORC

浏览/检索结果: 共9条,第1-9条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
2-Methoxyestradiol Self-Microemulsifying Drug Delivery System: Preparation, Characterization, and Evaluation In Vitro and In Vivo 期刊论文
2019, 卷号: 38, 期号: 7, 页码: 1290-1296
作者:  He, Suna;  Niu, Jingling;  Yang, Hui;  Zhang, Xiaoping;  Chen, Xiaojia
收藏  |  浏览/下载:58/0  |  提交时间:2020/01/03
SOX9/FXYD3/Src Axis Is Critical for ER thorn Breast Cancer Stem Cell Function 期刊论文
2019, 卷号: 17, 期号: 1, 页码: 238-249
作者:  Xue, Yue;  Lai, Lihua;  Lian, Wenwen;  Tu, Xintao;  Zhou, Jiaojiao
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/03
Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial 期刊论文
2019, 卷号: 112, 页码: 57-65
作者:  Yuan, Peng;  Hu, Xichun;  Sun, Tao;  Li, Wei;  Zhang, Qingyuan
收藏  |  浏览/下载:20/0  |  提交时间:2020/01/03
Clinical characteristics and spectrum of NF1 mutations in 12 unrelated Chinese families with neurofibromatosis type 1 期刊论文
2018, 卷号: 19, 期号: 1, 页码: 101
作者:  Mao, Bin;  Chen, Siyu;  Chen, Xin;  Yu, Xiumei;  Zhai, Xiaojia
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells 期刊论文
2016, 卷号: 5, 期号: 1, 页码: e1063772
作者:  Xiao, Peng;  Wan, Xiaopeng;  Cui, Bijun;  Liu, Yang;  Qiu, Chenyang
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/04
Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China 期刊论文
2016, 卷号: 7, 期号: 35, 页码: 57301-57309
作者:  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li;  Feng, Jifeng
收藏  |  浏览/下载:59/0  |  提交时间:2020/01/04
A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit 期刊论文
2015, 卷号: 75
作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li
收藏  |  浏览/下载:59/0  |  提交时间:2020/01/04
A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit 会议论文
CANCER RESEARCH, 2015-05-01
作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/04
National consensus in China on diagnosis and treatment of patients with advanced breast cancer 期刊论文
2015, 卷号: 4, 期号: 5, 页码: 557-573
作者:  Xu, Binghe;  Hu, Xichun;  Jiang, Zefei;  Li, Huiping;  Chen, Jiayi
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace